FluoroPharma Medical, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
FluoroPharma Medical, Inc. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $2.22 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-31.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2015-03-31
- FluoroPharma Medical, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2013-12-31 was $27.14K.
- FluoroPharma Medical, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2014 was $2.22M, a 0.36% decline from fiscal 2013.
- FluoroPharma Medical, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2013 was $2.23M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month |
|---|---|---|---|
| 2014-12-31 | $2.22M 10-K · filed 2015-03-31 | ||
| 2013-12-31 | $27.14K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25 | $2.23M 10-K · filed 2014-03-25 | |
| 2013-09-30 | $2.21M 10-Q · filed 2014-11-19 |